Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc
Search This Board: 
Last Post: 1/23/2020 8:15:18 PM - Followers: 661 - Board type: Free - Posts Today: 0

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.

 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.

ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in FacebookTwitter, LinkedIn & Google+
 
                                                                                       


 

NEWS



Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 

ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3
 
 
 

 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111

 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 

info@amarantus.com
pr@amarantus.com


Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com



IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475

ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 

 
 
                                                                            

 

AMBS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS News: Withdrawal of Offering Statement Under Regulation a (1-a-w) 01/10/2020 06:52:57 AM
AMBS News: Amended Registration a Offering Under the Securities Act of 1933 (1-a/a) 01/09/2020 05:13:09 PM
AMBS News: Registration a Offering Under the Securities Act of 1933 (1-a) 01/09/2020 05:06:33 PM
AMBS News: Amarantus Sub Elto Pharma Gets Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson's Disease 12/04/2019 08:17:24 AM
AMBS News: Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products 10/24/2019 09:52:00 AM
PostSubject
#128357  Sticky Note what are you talking about? JPetroInc 06/16/18 01:00:07 PM
#129159   Tesla Auto park - a new low for breezy1 01/23/20 08:15:17 PM
#129158   I made bank on this but only because breezy1 01/23/20 08:10:57 PM
#129157   Never higher a football player to run a breezy1 01/23/20 08:10:05 PM
#129156   Be very skeptical of any company putting Gerald SidVicious 01/15/20 10:46:08 AM
#129155   You should see see his back and forth JCacciabeve 01/14/20 02:38:09 PM
#129154   Would you trust this individual with your family's JPetroInc 01/14/20 06:07:48 AM
#129153   Todos is committing suicide by appointing Jerkoff Jerry SidVicious 01/09/20 10:20:41 AM
#129152   Mr. Gerald Commissiong new CEO of TOMDF Ej23ny 01/06/20 04:56:20 PM
#129151   On January 5, 2020, Todos Medical Ltd. (the Ej23ny 01/06/20 04:14:26 PM
#129150   were in the $0.01's JPetroInc 01/03/20 02:34:00 PM
#129149   We're not pals yet. sdy 01/03/20 01:07:22 PM
#129148   what's it to you pal? JPetroInc 01/03/20 07:02:55 AM
#129146   The CBD market size will grow 20 billion Ej23ny 01/02/20 05:25:10 PM
#129145   Pull up a 5 year chart factor in itwentdwnhwmch 01/02/20 04:23:10 PM
#129144   J, if GC is a lying sack, why sdy 01/02/20 03:12:20 PM
#129143   scummy MM trading amongst themselves to drive the pps JPetroInc 01/02/20 12:21:45 PM
#129142   This stock could be a diamond in the bunnyskates 01/02/20 10:22:18 AM
#129141   News is out... CrazyC 01/02/20 09:10:21 AM
#129140   The demand for the stock is high. I Ej23ny 01/01/20 05:00:00 PM
#129139   printing $0.012 JPetroInc 12/20/19 11:48:45 AM
#129138   Todos To Present At Upcoming 12th Annual LD sdy 12/06/19 11:44:32 AM
#129137   Aqua. Now that's a name I've not heard freegriff 12/04/19 04:35:22 PM
#129136   News is out... CrazyC 12/04/19 09:06:04 AM
#129135   How’s AMBS doing? Looking to buy shares Aqua 12/03/19 11:20:31 AM
#129134   Absolutely, hopefully they declare the dividend of todos Ej23ny 11/28/19 12:19:58 PM
#129133   That is a good thing...thanks for the update Golden_Cross 11/28/19 12:10:52 PM
#129132   Tier changed again from pink limited to pink current Ej23ny 11/28/19 12:05:00 PM
#129131   This is old information the information was verified Ej23ny 11/22/19 10:34:36 PM
#129130   $AMBS Tier_Change: Pink Current to Pink Limited Golden_Cross 11/22/19 03:38:52 AM
#129129   Great update today by kid Gerald! Smfh JCacciabeve 11/18/19 10:09:44 PM
#129128   LMFAO JPetroInc 11/14/19 09:22:43 PM
#129127   Wait, make some money? Are you kidding JCacciabeve 11/13/19 07:49:07 AM
#129126   I’m still waiting for when we should “be JCacciabeve 11/12/19 09:17:12 AM
#129125   its all about revenue, ROI, EPS, and a JPetroInc 11/12/19 06:51:45 AM
#129124   “ disease biomarkers literally ran away from Gerald Ej23ny 11/11/19 10:23:10 PM
#129123   This is the next run. So make some freegriff 11/11/19 09:55:46 PM
#129122   Vending Machines - really WTF Gerald? JPetroInc 11/11/19 09:09:20 PM
#129120   Transformational Funding Positions Amarantus Heading into 2014 Milestones JPetroInc 11/07/19 05:58:59 AM
#129119   Ive owned this crap for six years. Wrote only1de 11/06/19 01:06:34 PM
#129118   ~~~ What an F'n joke ~~~ JPetroInc 11/06/19 06:05:39 AM
#129117   https://ir.amarantus.com/press-releases/detail/2116/amarantus-enters-into-agreem Dick Goblair 11/05/19 04:31:54 PM
#129115   beware of peeps who speak for Gerald Commissiong JPetroInc 11/03/19 07:40:50 AM
#129114   I assure you - I know Gerald Commission well JPetroInc 11/02/19 09:26:49 PM
#129113   he didn't say he should be good based freegriff 11/02/19 12:34:02 PM
#129112   Gerald apparently told someone from another board that JCacciabeve 11/01/19 02:46:29 PM
#129111   “Vivek Ramaswamy trades top execs and adds stealthy Ej23ny 10/31/19 11:16:46 AM
#129109   cause AMBS entire portfolio is worthless? JPetroInc 10/29/19 10:18:33 PM
#129108   curious to know why would he give the Ej23ny 10/29/19 04:54:41 PM
#129107   Did I tell you of the time we JPetroInc 10/29/19 07:26:26 AM
#129106   I could be wrong. but I think back itwentdwnhwmch 10/28/19 04:59:49 PM
PostSubject